Literature DB >> 6470147

Pulmonary response of fifth component of complement-sufficient and -deficient mice to hyperoxia.

D A Parrish, B C Mitchell, P M Henson, G L Larsen.   

Abstract

The fifth component of complement, C5, can form fragments that cause neutrophil chemotaxis, oxygen radical production, and lysosomal enzyme release. The purpose of this study was to determine if C5 and these fragments contribute to the inflammation seen in pulmonary oxygen toxicity as defined by histology and analysis of bronchoalveolar lavage fluid (BALF). In addition, the role of C5 in producing mortality in the animals was addressed. Pairs of C5 deficient (C5-) and C5 sufficient (C5+) mice, 6 mo or older, were placed in a chamber and challenged with 95% oxygen at ambient pressure. A significant difference in mortality was observed after 200 h of exposure, i.e., 90% mortality in C5+ mice vs. 25% mortality in C5- mice (P less than 0.001). This difference in mortality was not seen when C5- mice were transfused with plasma that contained C5 derived from C5+ mice. Morphometric analysis of histologic sections with light microscopy revealed earlier pathologic changes in C5+ mice that was characterized by increased cellularity due in part to neutrophil influx into the alveolar-capillary wall. Transmission electron microscopy also confirmed an earlier inflammatory response in the C5+ mice with evidence of injury to alveolar epithelial cells, interstitial edema, and an increase in the cellular component of the interstitium. Analysis of BALF also demonstrated earlier abnormalities in C5+ mice, which included a significantly greater percentage of neutrophils in the C5+ mice at 117 h. Similar studies in younger mice of these strains again showed earlier neutrophil accumulation in C5+ mice, but the time course of the injury was more protracted. This study shows that the presence of C5 is associated with a greater mortality and an earlier influx of neutrophils into murine lungs. However, in the absence of C5, neutrophils will still immigrate into the lung and hyperoxic damage will occur at a later time point, which demonstrates the inherent redundancy of the inflammatory process.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6470147      PMCID: PMC425253          DOI: 10.1172/JCI111515

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

2.  Macrophage proteinase and inflammation: the production of chemotactic activity from the fifth complement by macrophage proteinase.

Authors:  R Snyderman; H Shin; A M Dannenberg
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

3.  Pulmonary inflammation due to oxygen toxicity: involvement of chemotactic factors and polymorphonuclear leukocytes.

Authors:  R B Fox; J R Hoidal; D M Brown; J E Repine
Journal:  Am Rev Respir Dis       Date:  1981-05

4.  C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils.

Authors:  P A Ward; J H Hill
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

5.  Reduction of the edema of acute hyperoxic lung injury by granulocyte depletion.

Authors:  D M Shasby; R B Fox; R N Harada; J E Repine
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-05

6.  Lung cell oxidant injury. Enhancement of polymorphonuclear leukocyte-mediated cytotoxicity in lung cells exposed to sustained in vitro hyperoxia.

Authors:  N Suttorp; L M Simon
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

7.  The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa.

Authors:  G L Larsen; B C Mitchell; T B Harper; P M Henson
Journal:  Am Rev Respir Dis       Date:  1982-08

8.  Acute immunologic pulmonary alveolitis.

Authors:  K J Johnson; P A Ward
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

9.  Quantitation and stability of the fifth component of complement (C5) in bronchoalveolar lavage fluids obtained from non-human primates.

Authors:  W P Kolb; L M Kolb; R A Wetsel; W R Rogers; J O Shaw
Journal:  Am Rev Respir Dis       Date:  1981-02

10.  Deficiency of the fifth component of complement in mice with an inherited complement defect.

Authors:  U R Nilsson; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

View more
  8 in total

1.  Characterization of murine monoclonal antibodies that recognize neutralizing epitopes on human C5a.

Authors:  J W Larrick; J Wang; B M Fendly; D E Chenoweth; S L Kunkel; T Deinhart
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

2.  Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.

Authors:  R C Strunk; D M Eidlen; R J Mason
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  Adult respiratory distress syndrome. A live E coli septic primate model.

Authors:  D H Hangen; R J Bloom; J H Stevens; P O'Hanley; M Ranchod; J Collins; T A Raffin
Journal:  Am J Pathol       Date:  1987-02       Impact factor: 4.307

4.  Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity.

Authors:  C W White; K B Avraham; P F Shanley; Y Groner
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

5.  Intercellular adhesion molecule-1 contributes to pulmonary oxygen toxicity in mice: role of leukocytes revised.

Authors:  C D Wegner; W W Wolyniec; A M LaPlante; K Marschman; K Lubbe; N Haynes; R Rothlein; L G Letts
Journal:  Lung       Date:  1992       Impact factor: 2.584

6.  Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates.

Authors:  J H Stevens; P O'Hanley; J M Shapiro; F G Mihm; P S Satoh; J A Collins; T A Raffin
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

7.  The influence of Nrf2 on cardiac responses to environmental stressors.

Authors:  Reuben Howden; Eva Gougian; Marcus Lawrence; Samantha Cividanes; Wesley Gladwell; Laura Miller-DeGraff; Page H Myers; D Clay Rouse; Robert B Devlin; Hye-Youn Cho; Steven R Kleeberger
Journal:  Oxid Med Cell Longev       Date:  2013-04-22       Impact factor: 6.543

Review 8.  Nrf2 and cardiovascular defense.

Authors:  Reuben Howden
Journal:  Oxid Med Cell Longev       Date:  2013-04-04       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.